Skip to main content
Clinical Trials/EUCTR2017-001543-13-DK
EUCTR2017-001543-13-DK
Active, not recruiting
Phase 1

Preliminary effect and safety of physiotherapy with strength training and protein-dense nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients with hip fracture - a randomized controlled pilot trial. (The HIP-SAP trial) - HIP-SAP trial

Morten Tange Kristensen/Hvidovre Hospital0 sites48 target enrollmentFebruary 1, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Area of investigation is recovery of muscle strength and function following hip fracture surgery.
Sponsor
Morten Tange Kristensen/Hvidovre Hospital
Enrollment
48
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2018
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Morten Tange Kristensen/Hvidovre Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients who have undergone surgery for a hip fracture at Amager\-Hvidovre University Hospital and admitted at the Hip Fracture Unit at the hospital
  • Age \>\=65 years
  • Ability to speak and understand Danish and with a Danish Social Security Number
  • Able to give written informed consent
  • Residing at home and with an independent pre\-fracture indoor walking ability (NMS\=2\)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • Postoperative weight\-bearing restrictions
  • Multiple fractures
  • Terminal illness
  • Patients unable/unwilling to cooperate on testing and rehabilitation
  • Planned/elective hospitalization within the trial period.
  • Cognitive dysfunction determined by chart review, reported by nursing staff, or observed by trained research staff (not alert or oriented, dementia, active delirium)
  • Uncontrolled blood pressure (systolic \> 150 mmHg, or diastolic \> 100 mmHg)
  • Heart disease in the form of peri\-, myo\- or endocarditis.
  • History of stroke with motor disability.
  • Heart failure (NYHA class III and IV)

Outcomes

Primary Outcomes

Not specified

Similar Trials